LUMBY, British Columbia, Oct. 30, 2009 (GLOBE NEWSWIRE) -- avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announces that the Company is in receipt of an order of the Supreme Court of the State of New York dated October 23, 2009 issued on an ex parte basis pursuant to a proceeding commenced by a family of investment funds (the "Investor") and seeking to enforce certain terms of the investment agreements between the Company and the Investor. The order includes certain injunctive relief relating to the investment agreements and directs the delivery of 35 Million shares of the Company's common stock.
The Company believes the court order was improperly obtained and has filed a motion to set the court order aside.
About avVaa World Health Care Products
avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com http://www.avvaa.com
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature.
Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.
Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.